Insmed officer sells 101,100 shares, exercises options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
INSMED Inc Chief People Strategy Officer Orlov S. Nicole Schaeffer exercised options on November 19, 2026, covering 55,400 shares at an exercise price of $30.46 and 45,700 shares at an exercise price of $26.43. She also reported sales of 90,299 shares at a weighted average price of $145.06, 8,539 shares at $146.76, and 2,262 shares at $147.50. The reported transactions were made under a Rule 10b5-1 trading plan adopted May 11, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F1, F6 | 55,400 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F1, F6 | 45,700 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 55,400 | $30.46 | $1.69M |
| Exercise | Common Stock F1 | 45,700 | $26.43 | $1.21M |
| Sale | Common Stock F1, F3 | 90,299 | $145.06 | $13.10M |
| Sale | Common Stock F1, F4 | 8,539 | $146.76 | $1.25M |
| Sale | Common Stock F1, F5 | 2,262 | $147.50 | $334K |
Footnotes (6)
- F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
- F3. This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F4. This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F5. This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F6. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sales price financial
Stock Option (right to buy) financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What INSM options did Orlov S. Nicole Schaeffer exercise, and at what prices?
AI-generated analysis. How Rhea-AI works. Not financial advice.